262-19185-38220 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-22
Registered in v-safe
2020-12-22
Dose 1 — Pfizer-BioNTech
2020-12-22
Health check-in — day 0, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2020-12-24
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Diarrhea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2020-12-24
Report sent to call center — days 1–6 daily, dose 1
Be unable to work · Be unable to do your normal daily activities

1 call case(s)
2020-12-25
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache

Adult check-in
2020-12-26
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-27
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-28
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-29
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-01-05
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-12
Dose 2 — Pfizer-BioNTech
2021-01-12
Health check-in — day 0, dose 2
Feeling: Good · None

Adult check-in
2021-01-13
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Adult check-in
2021-01-13
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-01-16
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Headache, Fatigue or tiredness

Adult check-in
2021-01-17
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Headache, Fatigue or tiredness

Adult check-in
2021-01-18
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-26
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-02
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-11
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-02-16
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-02-25
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-13
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-07-15
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-10-16
Dose 3 — Pfizer-BioNTech
2022-01-12
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in
2022-09-30
Dose 4 — Pfizer-BioNTech
2022-10-01
Health check-in — days 1–6 daily, dose 4
Feeling: Fair · Site: Pain · Headache

Adult check-in
2022-10-02
Health check-in — days 1–6 daily, dose 4
Feeling: Good · None

Adult check-in
2022-10-03
Health check-in — days 1–6 daily, dose 4
Feeling: Good · None

Adult check-in
2022-10-05
Health check-in — days 1–6 daily, dose 4
Feeling: Good · None

Adult check-in
2022-10-16
Survey response — day 14, dose 4
MedDRA: Laryngitis — Feeling: Fair

Free text: Laryngitis

MedDRA releases: 2024-11 · check-in free text available
2022-11-06
Health check-in — day 35, dose 4
Feeling: Good

Adult check-in
2022-11-11
Health check-in — day 42, dose 4
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-22	Pfizer-BioNTech
2	2021-01-12	Pfizer-BioNTech
3	2021-10-16	Pfizer-BioNTech	No
4	2022-09-30	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2020-12-24	priority 2/3
2021-01-13	priority 2/3

Free text

Release 12 — day 14, dose 4

2022-10-16

Symptoms: Laryngitis

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Laryngitis	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release